Crosstalk between Statins and Cancer Prevention and Therapy: An Update

Area of Science:

• Oncology
• Pharmacology

Background:

• Statins are recognized for their anticancer properties against various solid and diffuse cancers.
• Simvastatin, rosuvastatin, and atorvastatin are commonly used statins with demonstrated anti-tumor activity.
• Statins selectively induce apoptosis in cancer cells, a key mechanism in their anti-cancer effects.

Purpose of the Study:

• To explore the role of statins in cancer therapy.
• To investigate the mechanisms underlying statin's anti-tumor activity, including apoptosis induction and histone acetylation regulation.
• To evaluate the potential of combining statins with histone deacetylase inhibitors for enhanced anti-cancer effects.

Main Methods:

• Review of existing studies on statins and cancer.
• Analysis of the molecular mechanisms of statin action, focusing on apoptosis and histone acetylation.
• Exploration of combination therapy strategies involving statins and histone deacetylase inhibitors.

Main Results:

• Statins demonstrate significant anti-tumor activity against liver, lung, multiple myeloma, and leukemia cancers.
• Statin-induced apoptosis is a primary mechanism of their anti-cancer action.
• Disturbances in histone acetylation, linked to cancer progression, are modulated by statins.
• High levels of histone deacetylases in cancers suggest a therapeutic target.

Conclusions:

• Statins possess valuable anticancer properties, primarily through apoptosis induction and modulation of histone acetylation.
• Combining statins with histone deacetylase inhibitors presents a promising synergistic strategy for cancer treatment.
• Further research into statin-based combination therapies could lead to improved cancer treatment outcomes.